Cargando…
Genetic and epigenetic determinants of diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma and is notorious for its heterogeneity, aggressive nature, and the frequent development of resistance and/or relapse after treatment with standard chemotherapy. To address these problems, a strong emphasis has been placed on r...
Autores principales: | Bakhshi, Tanner J., Georgel, Philippe T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718920/ https://www.ncbi.nlm.nih.gov/pubmed/33277464 http://dx.doi.org/10.1038/s41408-020-00389-w |
Ejemplares similares
-
A Promising Future for Precision Epigenetic Therapy for Follicular and Diffuse Large B-Cell Lymphoma?
por: Chung, Clement
Publicado: (2022) -
Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma
por: Leveille, Etienne, et al.
Publicado: (2021) -
Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2014) -
Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012) -
Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)